Matthias Alder

Companies

• Gain Therapeutics, Inc.Chief executive officer Mar 27, 2023 to Mar 28, 2024¹
• Gain Therapeutics, Inc.Board member Sep 22, 2022 to Mar 28, 2024²
• Gain Therapeutics, Inc.Chief operating officer Dec 28, 2021 to Sep 22, 2022³
• Sucampo PharmaceuticalsEVP, Business Dev. & Licensing Nov 20, 2015 to Jul 7, 2017⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• GTGain Therapeutics, Inc. GANX21,140 shares⁵$26.3K at $1.25Mar 26, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 26, 2024Shares withheld for tax 6,085 shares at $4.06 of Gain Therapeutics, Inc.⁵
• Mar 26, 2024Exercised options 637 shares of Gain Therapeutics, Inc.⁵
• Mar 26, 2024Exercised options 825 shares of Gain Therapeutics, Inc.⁵
• Mar 26, 2024Exercised options 18,750 shares of Gain Therapeutics, Inc.⁵
• Dec 21, 2023Sold 206 shares at $2.46 of Gain Therapeutics, Inc.⁶
• Dec 20, 2023Exercised options 637 shares of Gain Therapeutics, Inc.⁶
• Dec 7, 2023Sold 1,820 shares at $2.50 of Gain Therapeutics, Inc.⁷
• Oct 1, 2023Exercised options 825 shares of Gain Therapeutics, Inc.⁸
• Sep 20, 2023Exercised options 2,550 shares of Gain Therapeutics, Inc.⁹
• Jul 1, 2023Exercised options 3,300 shares of Gain Therapeutics, Inc.¹⁰